Pushkal Garg, CMO & EVP Development & Med Affairs at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 574 shares at $157.30 ($89K) on 2024-02-28, disclosed to the SEC on 2024-02-29.
Open-market sale of $89k ALNY by CMO & EVP Development & Med Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $154.54 | 247 | $38K | 42.8% |
| 2 | $155.45 | 194 | $30K | 33.8% |
| 3 | $156.38 | 115 | $18K | 20.2% |
| 4 | $157.30 | 17 | $3K | 3.0% |
| 5 | $158.09 | 1 | $158 | 0.2% |
| Total | $155.30 avg | 574 |
| $89K |
| 100% |
| Filing → |
| ALNY | SELL | 2026-03-02 | $1.5M | — | Filing → |
| ALNY | SELL | 2026-02-17 | $695K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |